Case-Based Roundtable Meeting Spotlight September 2021: Solid Tumors

Jeffrey A. Sosman, MD leads a discussion about a 59-year-old Black who woman received a diagnosis of clear cell renal cell carcinoma.

Komal Jhaveri, MD, discussed the case of a 63-year-old patient with HER2-positive metastatic breast cancer during a Targeted Oncology Case-Base Roundtable event.

Molecular testing for a patient with lung cancer revealed a RET fusion and PD-L1 expression of 80%.

Richard S. Finn, MD and a group of peers discusses that case of a 77-year-old woman who presented to her primary care physician complaining of abdominal pain and fatigue.

In this case scenario, a 59-year-old White man presented with chest pain, cough, and dyspnea. The patient was later diagnosis with non–small cell lung cancer.

An 88-year-old man presented with a nonhealing ulcer on the lateral aspect of his nose. The patient was diagnosed with Basal cell carcinoma.

During a Targeted Oncology™ Cased-Based Roundtable event, Meghan Mooradian, MD, discussed the case of a 73-year-old patient with extensive stage-small cell lung cancer.

During a Targeted Oncology Case-Based Roundtable event, Petros Grivas, MD, PhD, discussed the case of a 75-year-old patient with castration-resistant prostate cancer.

A 58-year-old man presented with a solitary nodule on the neck, occasional shortness of breath, and intermittent excessive fatigue. Twelve months after being treated with systemic therapy, symptoms occurred leading the oncologist to discover metastatic disease.

During a Targeted Oncology Case-Based Roundtable event, Hossein Borghaei, DO, MS, moderated a discussion about a 59-year-old man with non–small cell lung cancer.

Based on 3 clinical trials, suggest that when managing toxicities in patients with non-metastatic castration-resistant prostate cancer, oncologists should look at the delta instead of the absolute numbers.

During a Targeted Oncology Case-Based Roundtable event, Mark Yarchoan, MD, moderates a discussion about a 77-year-old woman with Child Pugh B and C hepatocellular carcinoma.

During a Targeted OncologyTM Case-Based Roundtable event, Dan J. Raz, MD, MAS, and peers discussed the challenges of testing in lung cancer and treatment.